Induction of apoptosis by buckwheat trypsin inhibitor in chronic myeloid leukemia K562 cells

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 4, 2007, Pages 783-786

  Wang, Zhuan Hua ^a   Gao, Li ^a   Li, Yu Ying ^a   Zhang, Zheng ^a   Yuan, Jing Ming ^a   Wang, Hong Wei ^b   Zhang, Li ^b   Zhu, Lei ^b  

^a SHANXI UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Buckwheat; K562 cell; Trypsin inhibitor

Indexed keywords

TRYPSIN INHIBITOR;

APOPTOSIS; ARTICLE; BUCKWHEAT; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS;

APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FAGOPYRUM; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; RECOMBINANT PROTEINS; TRYPSIN INHIBITORS;

EID: 34147101289     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.783     Document Type: Article

References (20)

1. Sinnett D., Labuda D., Krajinovic M., Fam. Cancer, 5, 35-47 (2006).
2. Tchinda J., Volpert S., Berdel W. E., Buchner T., Horst J., Cancer Genet. Cytogenet., 165, 180-184 (2006).
3. Li L., Giannopoulos K., Reinhardt P., Tabarkiewicz J., Schmitt A., Greinner J., Rolinski J., Hus I., Dmoszynska A., Wiesneth M., Schmitt M., Int. J. Oncol., 28, 855-861 (2006).
4. Tickenbrock L., Muller-Tidow C., Berdel W. E., Serve H., Expert Opin. Emerg. Drugs, 11, 153-165 (2006).
5. Azzouz H., Cherqui A., Campan E. D., Rahbe Y., Duport G., Jouanin L., Kaiser L., Giordanengo P., J. Insect Physiol., 51, 75-86 (2005).
6. Rahbe Y., Ferrasson E., Rabesona H., Quillien L., Insect Biochem. Mol. Biol., 33, 299-306 (2003).
7. Mello M. O., Tanaka A. S., Silva-Filho M. C., Mol. Phylogenet. Evol., 27, 103-112 (2003).
8. Supuran C. T., Casini A., Scozzafava A., Med. Res. Rew., 5, 535-558 (2003).
9. Yavelow J., Finlay T. H., Kennedy A. R., Troll W., Cancer Res., 43, 2454-2459 (1983).
10. Htay H. H., Tsubouchi R., Haneda M., Murakami K., Yoshino M., Biomed. Res., 23, 127-134 (2002).
11. Gardner P. R., Methods Enzymol., 349, 9-23 (2002).
12. Foehr M. W., Tomei L. D., Goddard J. G., Pemberton P. A., Bathurst I. C., Nutr. Cancer, 34, 199-205 (1999).
13. Inoue K., Takano H., Yanagisawa R., Sakurai M., Shimada A., Yoshino S., Sato H., Yoshikawa T., Exp. Biol. Med. (Maywood), 230, 281-287 (2005).
14. Gladysheva I. P., Moroz N. A., Karmakova T. A., Nemtsova E. R., Yakubovskaya R. I., Larionova N. I., J. Drug Targeting, 9, 303-316 (2001).
15. Malkowicz S. B., Liu S. P., Broderick G. A., Wein A. J., Kennedy A. R., Levin R. M., Neurourol. Urodyn., 22, 54-57 (2003).
16. Wyllie A. H., Kerr J. F. K., Currie A. R., Int. Rev. Cytol., 68, 251-305 (1980).
17. Ashkenazi A., Dixit V. M., Science, 281, 1305-1313 (1998).
18. Enari M. Hug H., Nagata S., Nature (London), 375, 78-81 (1995).
19. Huang D. C., Strasser A., Cell, 103, 839-842 (2000).
20. Kobayashi K., Gotoh J., Hirashima Y., Terao T., J. Biol. Chem., 271, 11362-11367 (1996).